1.
Flowchart for inclusion of patients.
2.
Baseline characteristics of the study population * .
Pearson’s correlation between the Dutch STarT MSK tool and reference questionnaires.
Quadratic-weighted kappa for the Dutch STarT MSK tool * .
Proportions and relative risks of persistent disability at 3 months * .
Percentage of patients with intermediate-thickness (1.2–3.5 mm) melanoma on trunk or limb in Southern Netherlands who underwent SLNB (Sentinel Lymph Node Biopsy).
3.
4.
5.
Survival of patients with intermediate-thickness (1.2–3.5 mm) melanoma on trunk or limb in Southern Netherlands diagnosed 2000–2016 followed up until Feb 2021 by SLNB (Sentinel Lym...
Characteristics of patients with intermediate thickness cutaneous melanoma (1.2–3.5 mm) on trunk or limb (n = 1989) diagnosed 2000–2016 in the Southern Netherlands.
Hazard Ratios (HR) of patients with intermediate-thickness (1.2–3.5 mm) melanoma diagnosed 2010–2016, followed-up until February 2021.
Studies on melanoma comparing outcome of SLNB and excision versus Obs (observation) after excision only.